secwatch.observer — SEC 8-K summary
======================================

Issuer:     FORUM MARKETS Inc (FRMM)
CIK:        0001690080
Form:       8-K
Filed at:   2023-11-16T23:59:59+00:00
Accession:  0001213900-23-087933
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

180 Life Sciences gets Nasdaq extension to Dec 15 for Rule 5635(d) compliance; new equity deficiency notice
--------------------------------------------------------------------------------

- Nasdaq granted extension until Dec 15, 2023 to complete transactions to comply with Listing Rule 5635(d) regarding shareholder approval.
- On Nov 15, 2023, Nasdaq notified noncompliance with minimum $2.5M stockholders' equity; company had ($149,327) deficit as of Sept 30, 2023.
- Company must submit equity compliance plan by Jan 2, 2024; if accepted, may get up to 180 days extension.
- Company also noncompliant with bid price rule and Rule 5635(d); failure could lead to delisting with appeal rights.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1690080/000121390023087933/0001213900-23-087933-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1690080/000121390023087933/ea188599-8k_180life.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-087933

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer